Brain Injuries, Acute
8
3
4
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
12.5%
1 terminated out of 8 trials
66.7%
-19.8% vs benchmark
13%
1 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Brain Recovery With Automated VEntilation
Antiseizure Medication in Seizure Networks at Early Acute Brain Injury
Screening Emotions in Adolescents at the Hospital for mTBI
Severe Acquired Brain Injuries: Prognostic Factors and Quality of Care
The Relationship Between Brain Injury Biomarkers in Cerebrospinal Fluid and Blood of Patients After Cardiac Arrest and Prognosis
Autologous Stem Cell Study for Adult TBI (Phase 2b)
Acustocerebrography (ACG) in Severe Brain Injury
Signal Analysis for Neurocritical Patients